Genetic Risk Score for Pancreatic Cancer Prediction
Treatments studied
Part of Cancer, Digestive system, Hormones & metabolism clinical trials.
This study tests a genetic tool that analyzes your DNA to estimate your personal risk of developing pancreatic cancer. The goal is to help doctors identify who might be at higher risk and potentially catch the disease earlier.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You can understand the study and agree to participate
- You either have been diagnosed with pancreatic ductal adenocarcinoma (pancreatic cancer) or do not have it
- Your medical records and biological samples (like blood or tissue) are available and complete for analysis
- You are in good enough health to participate, as determined by the research team
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study offers genetic testing and counseling for people at higher risk of pancreatic cancer. It aims to see if offering these services helps people learn about their risk and get screened earlier.
This study is a registry for people at high risk for pancreatic cancer. Researchers will collect information over time to learn more about how to detect and prevent the disease.
This trial tests ways to screen people who have a family-passed (inherited) gene mutation linked to higher pancreatic cancer risk. The goal is to find pancreatic cancer earlier and improve how screening is done for people at increased risk.
This trial uses MRI and endoscopic ultrasound to look for early signs of pancreatic cancer in people who have a high risk due to their genes or family history. Finding it early may lead to better treatment options.
This study builds a database of people at higher risk for pancreatic cancer (or certain early warning findings) to help find better ways to detect the disease early. You may be asked to complete health questionnaires and possibly donate a blood/saliva/swab sample.
This study screens people at high risk for pancreatic cancer using imaging tests. It aims to catch cancer early in those with certain genetic conditions or strong family history.
Hear when a new Pancreatic Ductal Adenocarcinoma (mPDAC) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.